FridayOL

Zepbound Coverage Controversy: CVS Health's Decision Sparks Debate and Impacts Lilly's Stock

The Associated Press

Zepbound's Rising Popularity Meets Coverage Hurdles Eli Lilly's groundbreaking weight-loss drug, Zepbound, has taken the market by storm, demonstrating remarkable efficacy in helping individuals achieve significant weight loss. However, the drug's r ...Read more